Beyond-THC Chemovar Evaluation Survey
The Society of Cannabis Clinicians developed a survey in 2011 that asked about patients’ responses to CBD-rich cannabis.
Archive for month: August, 2011
The dual neuroprotective-neurotoxic profile of cannabinoid drugs.
British Journal of Pharmacology, August 2011
—
Extensive in vitro and in vivo studies have shown that cannabinoid drugs have neuroprotective properties and suggested that the endocannabinoid system may be involved in endogenous neuroprotective mechanisms. On the other hand, neurotoxic effects of cannabinoids in vitro and i…
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
British Journal of Pharmacology, August 2011
—
Tetrahydrocannabinol (THC) has been the primary focus of cannabis research since 1964, when Raphael Mechoulam isolated and synthesized it. More recently, the synergistic contributions of cannabidiol to cannabis pharmacology and analgesia have been scientifically demonstrated…
Cannabis in palliative medicine: improving care and reducing opioid-related morbidity.
American Journal of Hospice and Palliative Medicine, August 2011
—
Unlike hospice, long-term drug safety is an important issue in palliative medicine. Opioids may produce significant morbidity. Cannabis is a safer alternative with broad applicability for palliative care. Yet the Drug Enforcement Agency (DEA) classifies cannabis as Schedule I…
Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.
Breast Cancer Research and Treatment, August 2011
—
Invasion and metastasis of aggressive breast cancer cells are the final and fatal steps during cancer progression. Clinically, there are still limited therapeutic interventions for aggressive and metastatic breast cancers available. Therefore, effective, targeted, and non-toxi…
Treatment of Crohn’s disease with cannabis: an observational study.
Israel Medical Association Journal, August 2011
—
BACKGROUND: The marijuana plant cannabis is known to have therapeutic effects, including improvement of inflammatory processes. However, no report of patients using cannabis for Crohn’s disease (CD) was ever published. OBJECTIVES: To describe the effects of cannabis use in pat…